Showing results (251-260 of 267) with videos related to
Sort By:
Pageof 27
Acta Haematologica|August 17, 2022
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan AfricaLuke R Smart, Emmanuela E Ambrose, Georgina Balyorugulu, et al.Journal of Community Genetics|May 17, 2020
Empowering newborn screening programs in African countries through establishment of an international collaborative effortBradford L Therrell, Michele A Lloyd-Puryear, Kwaku Ohene-Frempong, et al.Blood Advances|November 15, 2018
Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian childrenPatrick T McGann, Anne M Williams, Graham Ellis, et al.British Journal of Haematology|January 5, 2023
Genome-wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel lociEric Jay Earley, Shannon Kelly, Fang Fang, et al.Mbio|January 25, 2022
Assessment of Plasmodium falciparum Artemisinin Resistance Independent of kelch13 Polymorphisms and with Escalating Malaria in BangladeshMaisha Khair Nima, Angana Mukherjee, Saiful Arefeen Sazed, et al.Blood Advances|January 17, 2025
Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trialRosa M Nieves, Teresa Latham, Nicolle Marte, et al.Pediatric Blood & Cancer|September 5, 2009
The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study designBruce W Thompson, Scott T Miller, Zora R Rogers, et al.JAMA|September 10, 2014
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel membersBarbara P Yawn, George R Buchanan, Araba N Afenyi-Annan, et al.Blood Advances|September 30, 2025
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populationsAlexandra Power-Hays, Kathryn E McElhinney, Thomas N Williams, et al.The New England Journal of Medicine|June 15, 2019
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell DiseaseElliott Vichinsky, Carolyn C Hoppe, Kenneth I Ataga, et al.Pageof 27